<?xml version="1.0" encoding="UTF-8"?>





<rss xmlns:itunes="http://www.itunes.com/DTDs/Podcast-1.0.dtd" version="2.0">


 





 




	







 








	 	 
<channel>
<title>CROI 2017  - CROI 2017</title>
<itunes:author>CROI</itunes:author>
<description>CROI 2017  - CROI 2017: Press Conference Sessions</description>
<itunes:summary>CROI 2017  - CROI 2017: Press Conference Sessions</itunes:summary>    
<link>http://www.croiconference.org/</link>
<language>en-us</language>
<copyright>Copyright 2017, CROI. All Rights Reserved.</copyright>
<itunes:category>Podcasts</itunes:category>
 
         
<webMaster>support@capitalreach.com</webMaster>
 
        
  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	
















	



	


 
	
 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>MONDAY PRESS CONFERENCE</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/33330.mp3?mediaType=feedmp3</link>
<description>
 Susan P. Buchbinder of CROI Chair and University of California, San Francisco, CA, USA
 Judith Currier of CROI Vice Chair and University of California, Los Angeles, CA, USA
 Richard Koup of CROI Vice Chair and National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/33330.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/33330.mp3</guid>	
 
<itunes:summary>MONDAY PRESS CONFERENCE

 Susan P. Buchbinder of CROI Chair and University of California, San Francisco, CA, USA
 Judith Currier of CROI Vice Chair and University of California, Los Angeles, CA, USA
 Richard Koup of CROI Vice Chair and National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	
















	



	


 
	
 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>MONDAY PRESS CONFERENCE</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/33331.mp3?mediaType=feedmp3</link>
<description>
"CHAIR" by Joseph Eron of University of North Carolina, Chapel Hill, NC, USA
"OA4:  DISCOVERY OF NOVEL POTENT HIV CAPSID INHIBITORS WITH LONG-ACTING POTENTIAL" by Winston Tse of Gilead Scis, Inc, Foster City, CA, USA
"OA4:  RANDOMIZED TRIAL OF BICTEGRAVIR OR DOLUTEGRAVIR WITH FTC/TAF FOR INITIAL HIV THERAPY" by Paul Sax of Brigham and Women's Hosp, Boston, MA, USA
"OA4:  PREVALENCE AND IMPACT OF PRETREATMENT DRUG RESISTANCE IN THE ANRS 12249 TASP TRIAL" by Anne Derache of Africa Hlth Rsr Inst, Mtubatuba, South Africa
"OA4:  PHASE III SWORD 1&amp;2: SWITCH TO DTG+RPV MAINTAINS VIROLOGIC SUPPRESSION THROUGH 48 WKS" by Josep M. Llibre of Univ Hosp Germans Trias, Badalona, Barcelona, Spain
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/33331.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/33331.mp3</guid>	
 
<itunes:summary>MONDAY PRESS CONFERENCE

"CHAIR" by Joseph Eron of University of North Carolina, Chapel Hill, NC, USA
"OA4:  DISCOVERY OF NOVEL POTENT HIV CAPSID INHIBITORS WITH LONG-ACTING POTENTIAL" by Winston Tse of Gilead Scis, Inc, Foster City, CA, USA
"OA4:  RANDOMIZED TRIAL OF BICTEGRAVIR OR DOLUTEGRAVIR WITH FTC/TAF FOR INITIAL HIV THERAPY" by Paul Sax of Brigham and Women's Hosp, Boston, MA, USA
"OA4:  PREVALENCE AND IMPACT OF PRETREATMENT DRUG RESISTANCE IN THE ANRS 12249 TASP TRIAL" by Anne Derache of Africa Hlth Rsr Inst, Mtubatuba, South Africa
"OA4:  PHASE III SWORD 1&amp;2: SWITCH TO DTG+RPV MAINTAINS VIROLOGIC SUPPRESSION THROUGH 48 WKS" by Josep M. Llibre of Univ Hosp Germans Trias, Badalona, Barcelona, Spain

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	
















	



	


 
	
 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>TUESDAY PRESS CONFERENCE</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/33384.mp3?mediaType=feedmp3</link>
<description>
"CHAIR" by Elaine Abrams of Columbia University, New York, NY, USA
"OA2: RANDOMIZED TRIAL OF LEEP VS CRYOTHERAPY TO TREAT CIN2/3 IN HIV-INFECTED WOMEN" by Sharon Greene of Univ of Washington, Seattle, WA, USA
"OA2: INTEGRATION OF POSTNATAL SERVICES IMPROVES MCH AND ART OUTCOMES: A RANDOMISED TRIAL" by Landon Myer of Univ of Cape Town, Cape Town, South Africa
"OA2: ADVERSE BIRTH OUTCOMES DIFFER BY ART REGIMEN FROM CONCEPTION IN BOTSWANA" by Rebecca Zash of Beth Israel Deaconess Med Cntr, Boston, MA, USA
"OA2: EFFECT OF POINT-OF-CARE TESTING ON ANTIRETROVIRAL-THERAPY INITIATION RATES IN INFANTS" by Ilesh Jani of Instituto Nacional de Saude, Maputo, Mozambique
"OA2: TREATMENT OF ACUTE HIV INFECTION IN NEONATES" by Louise Kuhn of Columbia Univ, New York, NY, USA
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/33384.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/33384.mp3</guid>	
 
<itunes:summary>TUESDAY PRESS CONFERENCE

"CHAIR" by Elaine Abrams of Columbia University, New York, NY, USA
"OA2: RANDOMIZED TRIAL OF LEEP VS CRYOTHERAPY TO TREAT CIN2/3 IN HIV-INFECTED WOMEN" by Sharon Greene of Univ of Washington, Seattle, WA, USA
"OA2: INTEGRATION OF POSTNATAL SERVICES IMPROVES MCH AND ART OUTCOMES: A RANDOMISED TRIAL" by Landon Myer of Univ of Cape Town, Cape Town, South Africa
"OA2: ADVERSE BIRTH OUTCOMES DIFFER BY ART REGIMEN FROM CONCEPTION IN BOTSWANA" by Rebecca Zash of Beth Israel Deaconess Med Cntr, Boston, MA, USA
"OA2: EFFECT OF POINT-OF-CARE TESTING ON ANTIRETROVIRAL-THERAPY INITIATION RATES IN INFANTS" by Ilesh Jani of Instituto Nacional de Saude, Maputo, Mozambique
"OA2: TREATMENT OF ACUTE HIV INFECTION IN NEONATES" by Louise Kuhn of Columbia Univ, New York, NY, USA

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	
















	



	


 
	
 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>TUESDAY PRESS CONFERENCE</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/33385.mp3?mediaType=feedmp3</link>
<description>
"CHAIR" by Kevin M. De Cock of Centers for Disease Control and Prevention, Nairobi, Kenya
"OA3: HIV INCIDENCE, PREVALENCE, AND UNDIAGNOSED INFECTIONS IN MEN WHO HAVE SEX WITH MEN" by Sonia Singh of CDC, Atlanta, GA, USA
"OA3: VIRAL-LOAD DYNAMICS AMONG PERSONS WITH DIAGNOSED HIV: UNITED STATES, 2014" by Nicole Crepaz of CDC, Atlanta, GA, USA
"OA3: COMBINATION HIV PREVENTION AND HIV INCIDENCE IN RAKAI, UGANDA" by Mary Grabowski of The Johns Hopkins Univ, Baltimore, MD, USA
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/33385.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/33385.mp3</guid>	
 
<itunes:summary>TUESDAY PRESS CONFERENCE

"CHAIR" by Kevin M. De Cock of Centers for Disease Control and Prevention, Nairobi, Kenya
"OA3: HIV INCIDENCE, PREVALENCE, AND UNDIAGNOSED INFECTIONS IN MEN WHO HAVE SEX WITH MEN" by Sonia Singh of CDC, Atlanta, GA, USA
"OA3: VIRAL-LOAD DYNAMICS AMONG PERSONS WITH DIAGNOSED HIV: UNITED STATES, 2014" by Nicole Crepaz of CDC, Atlanta, GA, USA
"OA3: COMBINATION HIV PREVENTION AND HIV INCIDENCE IN RAKAI, UGANDA" by Mary Grabowski of The Johns Hopkins Univ, Baltimore, MD, USA

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	
















	



	


 
	
 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>TUESDAY PRESS CONFERENCE</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/33386.mp3?mediaType=feedmp3</link>
<description>
"CHAIR" by David Thomas of Johns Hopkins School of Medicine, Baltimore, MD, USA
"TD17: ZIKA VIRUS PERSISTENCE IN BODY FLUIDS" by Gabriela Paz-Bailey of CDC, Atlanta, GA, USA
"TD17: NEUROLOGIC CONSEQUENCES OF POSTNATAL ZIKA VIRUS INFECTION IN INFANTS" by Maud Mavigner of Emory Univ, Atlanta, GA, USA
"TD17: ZIKA VIRUS PROTECTION BY A SINGLE LOW-DOSE NUCLEOSIDE-MODIFIED MRNA VACCINATION" by Michael Hogan of Univ of Pennsylvania, Philadelphia, PA, USA
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/33386.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/33386.mp3</guid>	
 
<itunes:summary>TUESDAY PRESS CONFERENCE

"CHAIR" by David Thomas of Johns Hopkins School of Medicine, Baltimore, MD, USA
"TD17: ZIKA VIRUS PERSISTENCE IN BODY FLUIDS" by Gabriela Paz-Bailey of CDC, Atlanta, GA, USA
"TD17: NEUROLOGIC CONSEQUENCES OF POSTNATAL ZIKA VIRUS INFECTION IN INFANTS" by Maud Mavigner of Emory Univ, Atlanta, GA, USA
"TD17: ZIKA VIRUS PROTECTION BY A SINGLE LOW-DOSE NUCLEOSIDE-MODIFIED MRNA VACCINATION" by Michael Hogan of Univ of Pennsylvania, Philadelphia, PA, USA

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	
















	



	


 
	
 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>WEDNESDAY PRESS CONFERENCE</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/33488.mp3?mediaType=feedmp3</link>
<description>
"CHAIR" by Constance A Benson of University of California at San Diego, San Diego, CA, USA
"OA7: A MULTICENTER DIAGNOSTIC ACCURACY STUDY OF THE XPERT ULTRA FOR TUBERCULOSIS DIAGNOSIS" by Timothy Rodwell of FIND, Geneva, Switzerland
"OA7: SIX-MONTH IPT REDUCES MORTALITY INDEPENDENTLY OF ART IN AFRICAN ADULTS WITH HIGH CD4" by Anani Badje of INSERM, Bordeaux, France
"OA7: RANDOMIZED CONTROLLED TRIAL OF PREDNISONE FOR PREVENTION OF PARADOXICAL TB-IRIS" by Graeme Meintjes of Univ of Cape Town, Cape Town, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/33488.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/33488.mp3</guid>	
 
<itunes:summary>WEDNESDAY PRESS CONFERENCE

"CHAIR" by Constance A Benson of University of California at San Diego, San Diego, CA, USA
"OA7: A MULTICENTER DIAGNOSTIC ACCURACY STUDY OF THE XPERT ULTRA FOR TUBERCULOSIS DIAGNOSIS" by Timothy Rodwell of FIND, Geneva, Switzerland
"OA7: SIX-MONTH IPT REDUCES MORTALITY INDEPENDENTLY OF ART IN AFRICAN ADULTS WITH HIGH CD4" by Anani Badje of INSERM, Bordeaux, France
"OA7: RANDOMIZED CONTROLLED TRIAL OF PREDNISONE FOR PREVENTION OF PARADOXICAL TB-IRIS" by Graeme Meintjes of Univ of Cape Town, Cape Town, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	
















	



	


 
	
 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>WEDNESDAY PRESS CONFERENCE</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/33489.mp3?mediaType=feedmp3</link>
<description>
"CHAIR" by Wafaa El-Sadr of ICAP at Columbia University, New York, NY, USA
"OA8: RESISTANCE EMERGENCE IN MACAQUES ADMINISTERED CABOTEGRAVIR LA DURING ACUTE INFECTION" by Gerardo Garcia-Lerma of CDC, Atlanta, GA, USA
"OA8: DAILY ORAL PREP IS EFFECTIVE AMONG WOMEN WITH ABNORMAL VAGINAL MICROBIOTA" by Renee Heffron of Univ of Washington, Seattle, WA, USA
"OA8: IMPACT OF VAGINAL MICROBIOTA ON GENITAL TISSUE AND PLASMA CONCENTRATIONS OF TENOFOVIR" by Sharon Hillier of Univ of Pittsburgh, Pittsburgh, PA, USA
"OA8: ON DEMAND POST EXPOSURE PROPHYLAXIS WITH DOXYCYCLINE FOR MSM ENROLLED IN A PREP TRIAL" by Jean-Michel Molina of St. Louis, Hosp, Paris, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/33489.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/33489.mp3</guid>	
 
<itunes:summary>WEDNESDAY PRESS CONFERENCE

"CHAIR" by Wafaa El-Sadr of ICAP at Columbia University, New York, NY, USA
"OA8: RESISTANCE EMERGENCE IN MACAQUES ADMINISTERED CABOTEGRAVIR LA DURING ACUTE INFECTION" by Gerardo Garcia-Lerma of CDC, Atlanta, GA, USA
"OA8: DAILY ORAL PREP IS EFFECTIVE AMONG WOMEN WITH ABNORMAL VAGINAL MICROBIOTA" by Renee Heffron of Univ of Washington, Seattle, WA, USA
"OA8: IMPACT OF VAGINAL MICROBIOTA ON GENITAL TISSUE AND PLASMA CONCENTRATIONS OF TENOFOVIR" by Sharon Hillier of Univ of Pittsburgh, Pittsburgh, PA, USA
"OA8: ON DEMAND POST EXPOSURE PROPHYLAXIS WITH DOXYCYCLINE FOR MSM ENROLLED IN A PREP TRIAL" by Jean-Michel Molina of St. Louis, Hosp, Paris, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	
















	



	


 
	
 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>WEDNESDAY PRESS CONFERENCE</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/33490.mp3?mediaType=feedmp3</link>
<description>
"CHAIR" by Susan P. Buchbinder of CROI Chair and University of California, San Francisco, CA, USA
"TD14: "HOOKED ON PAINKILLERS" PRIOR TO FIRST INJECTION AMONG PWID IN 16 U.S. CITIES" by Dita Broz of CDC, Atlanta, GA, USA
"TD14: CHANGES IN PRESCRIPTION OPIOID, METH, AND COCAINE USE AMONG MSM IN 20 U.S. CITIES" by Brooke Hoots of CDC, Atlanta, GA, USA
"TD14: INCREASING METHAMPHETAMINE USE AMONG NON-MSM WHO INJECT DRUGS IN KING COUNTY, WA" by Sara Glick of Univ of Washington, Seattle, WA, USA
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/33490.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/33490.mp3</guid>	
 
<itunes:summary>WEDNESDAY PRESS CONFERENCE

"CHAIR" by Susan P. Buchbinder of CROI Chair and University of California, San Francisco, CA, USA
"TD14: "HOOKED ON PAINKILLERS" PRIOR TO FIRST INJECTION AMONG PWID IN 16 U.S. CITIES" by Dita Broz of CDC, Atlanta, GA, USA
"TD14: CHANGES IN PRESCRIPTION OPIOID, METH, AND COCAINE USE AMONG MSM IN 20 U.S. CITIES" by Brooke Hoots of CDC, Atlanta, GA, USA
"TD14: INCREASING METHAMPHETAMINE USE AMONG NON-MSM WHO INJECT DRUGS IN KING COUNTY, WA" by Sara Glick of Univ of Washington, Seattle, WA, USA

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	
















	



	


 
	
 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>THURSDAY PRESS CONFERENCE</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/33606.mp3?mediaType=feedmp3</link>
<description>
"CHAIR" by David Thomas of Johns Hopkins School of Medicine, Baltimore, MD, USA
"OA9: MODELING HIV-HCV EPIDEMIOLOGY IN THE DAA ERA: THE ROAD TO ERADICATION" by Victor Virlogeux of INSERM, Lyon, France
"OA9: SUBSTANTIAL DECLINE IN ACUTE HCV INFECTIONS AMONG DUTCH HIV+ MSM AFTER DAA ROLL OUT" by Bart Rijnders of Erasmus Univ Med Cntr, Rotterdam, Netherlands
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/33606.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/33606.mp3</guid>	
 
<itunes:summary>THURSDAY PRESS CONFERENCE

"CHAIR" by David Thomas of Johns Hopkins School of Medicine, Baltimore, MD, USA
"OA9: MODELING HIV-HCV EPIDEMIOLOGY IN THE DAA ERA: THE ROAD TO ERADICATION" by Victor Virlogeux of INSERM, Lyon, France
"OA9: SUBSTANTIAL DECLINE IN ACUTE HCV INFECTIONS AMONG DUTCH HIV+ MSM AFTER DAA ROLL OUT" by Bart Rijnders of Erasmus Univ Med Cntr, Rotterdam, Netherlands

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	
















	



	


 
	
 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>THURSDAY PRESS CONFERENCE</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/33607.mp3?mediaType=feedmp3</link>
<description>
"CHAIR" by Peter Hunt of University of California, San Francisco, CA, USA
"OA12: IL-1&amp;BETA; INHIBITION SIGNIFICANTLY REDUCES ATHEROSCLEROTIC INFLAMMATION IN TREATED HIV" by Priscilla Hsue of Univ of California San Francisco, San Francisco, CA, USA
"OA12: ASSOCIATION BETWEEN CARDIOVASCULAR DISEASE &amp; CONTEMPORARILY USED PROTEASE INHIBITORS" by Lene Ryom of CHIP, Copenhagen, Denmark
"OA12: CESSATION OF CIGARETTE SMOKING AND THE IMPACT ON CANCER INCIDENCE IN THE D:A:D STUDY" by Leah Shepherd of Univ Coll London, London, UK
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/33607.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/33607.mp3</guid>	
 
<itunes:summary>THURSDAY PRESS CONFERENCE

"CHAIR" by Peter Hunt of University of California, San Francisco, CA, USA
"OA12: IL-1&amp;BETA; INHIBITION SIGNIFICANTLY REDUCES ATHEROSCLEROTIC INFLAMMATION IN TREATED HIV" by Priscilla Hsue of Univ of California San Francisco, San Francisco, CA, USA
"OA12: ASSOCIATION BETWEEN CARDIOVASCULAR DISEASE &amp; CONTEMPORARILY USED PROTEASE INHIBITORS" by Lene Ryom of CHIP, Copenhagen, Denmark
"OA12: CESSATION OF CIGARETTE SMOKING AND THE IMPACT ON CANCER INCIDENCE IN THE D:A:D STUDY" by Leah Shepherd of Univ Coll London, London, UK

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	
















	



	


 
	
 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>THURSDAY PRESS CONFERENCE</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/33608.mp3?mediaType=feedmp3</link>
<description>
"CHAIR" by Peter Hunt of University of California, San Francisco, CA, USA
"OA11: VIRAL CONTROL INDUCED BY HIVCONSV VACCINES &amp; ROMIDEPSIN IN EARLY TREATED INDIVIDUALS" by Beatriz Mothe of IrsiCaixa AIDS Rsr Inst, Badalona, Spain
"OA11: NO EVIDENCE OF ONGOING HIV REPLICATION AFTER 7 YEARS ON ART" by Mary Kearney of NCI, Frederick, MD, USA
"PS4: RESURGENCE OF HIV-1 FOUNDER VIRUSES FOLLOWING ANTIRETROVIRAL TREATMENT INTERRUPTION" by Morgane Rolland of US Military HIV Rsr Prog, Silver Spring, MD, USA
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/33608.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/33608.mp3</guid>	
 
<itunes:summary>THURSDAY PRESS CONFERENCE

"CHAIR" by Peter Hunt of University of California, San Francisco, CA, USA
"OA11: VIRAL CONTROL INDUCED BY HIVCONSV VACCINES &amp; ROMIDEPSIN IN EARLY TREATED INDIVIDUALS" by Beatriz Mothe of IrsiCaixa AIDS Rsr Inst, Badalona, Spain
"OA11: NO EVIDENCE OF ONGOING HIV REPLICATION AFTER 7 YEARS ON ART" by Mary Kearney of NCI, Frederick, MD, USA
"PS4: RESURGENCE OF HIV-1 FOUNDER VIRUSES FOLLOWING ANTIRETROVIRAL TREATMENT INTERRUPTION" by Morgane Rolland of US Military HIV Rsr Prog, Silver Spring, MD, USA

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


	
 
</channel>
</rss>
